Old Web
English
Sign In
Acemap
>
authorDetail
>
Op Hansen
Op Hansen
Cancer research
Chemotherapy
Myeloid leukemia
Daunorubicin
Aclarubicin
2
Papers
88
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial
1997
Leukemia
P de Nully Brown
T. Hoffmann
Op Hansen
A. M. Boesen
K Grønbæk
Erik Hippe
M. K. Jensen
K. Thorling
Hans H. Storm
Jens Pedersen-Bjergaard
Show All
Source
Cite
Save
Citations (12)
Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.
1991
Leukemia
Op Hansen
Pedersen-Bjergaard J
Jørgen Ellegaard
Brincker H
A. M. Boesen
Bjarne Egelund Christensen
Aage Drivsholm
Erik Hippe
Henning Jans
Jensen Kb
Show All
Source
Cite
Save
Citations (76)
1